In association with

Remaining advisers must pay for others’ insolvency

Philip Ryley

Forced retirement can be justified

Home > Investments > Equities

OrbiMed trust to raise £50m in placing plan

The £77.3m Biotech Growth Trust, run by OrbiMed, is raising as much as £50m through a placing of new ordinary shares, which closes on November 30.

Article Tools

visible-status-Standard story-url-IA p27 301109 Biotech.xml

Related Special Reports

  • Multi-Manager - May 2012

    Some wonder whether multi-manager funds are worth the money, and therefore the performance of the sector comes under close scrutiny

  • Multi-Manager - May 2012

    Some wonder whether multi-manager funds are worth the money, and therefore the performance of the sector comes under close scrutiny

  • Mid-Year Monitor - May 2012

    This annual special report examines the key issues likely to affect markets in the second half of 2012

See all reports
More on FTAdviser
FTA jobs